DF Schoonbrood, R Lutter, FJ Habets, CM Roos, HM Jansen and TA Out
Department of Pulmonology, Academic Medical Center, Amsterdam, The Netherlands.

In order to assess the usefulness of sputum analysis in studying plasma- protein exudation and local secretion of proteins in the airways, we measured specific proteins in the sputum sol phase (SSP) and sputum gel phase (SGP) from patients with stable asthma or chronic obstructive pulmonary disease (COPD). Protein levels in SSP showed relatively small variations between two subsequent visits of each patient (n = 22), as also reflected by intraclass correlation coefficients above 0.79. Protein levels differed between SSP and SGP, but inclusion of the SGP data did not affect the variation of protein levels in sputum. The degree of plasma-protein leakage was estimated from the relative coefficients of excretion (RCE) of alpha 2-macroglobulin and albumin (QA2M/QALB), and of alpha 2-macroglobulin and ceruloplasmin (QA2M/QCP), which do not depend on variable dilution of sputum. Despite the heterogeneity of the study group of 26 patients with asthma (atopic [13] smokers [13], including five patients using inhaled steroids), QA2M/QALB and QA2M/QCP correlated both with bronchial hyperreactivity (Spearman rank: r = -0.45 and r = -0.36, p < 0.05) and with blood eosinophil counts (r = 0.37 and 0.56, p < 0.05). We conclude that protein levels in SSP are relatively constant in patients with stable asthma or COPD; in patients with asthma, the plasma-protein leakage, as measured with the RCE in SSP, appears to correlate with indirect indices of airway inflammation.

This article has been cited by other articles:

				D. C Grootendorst, S. A Gauw, R. M Verhoosel, P. J Sterk, J. J Hospers, D. Bredenbroker, T. D Bethke, P. S Hiemstra, and K. F Rabe Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD Thorax, December 1, 2007; 62(12): 1081 - 1087. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: P.L. Paggiaro, Members of the Working Group:, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, P. Maestrelli, and P.J. Sterk Sputum induction Eur. Respir. J., July 1, 2002; 20(37_suppl): 3S - 8s. [Full Text] [PDF]

				Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic Analysis of fluid{-}phase mediators Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s. [Full Text] [PDF]

				E. L. J. Van Rensen, P. S. Hiemstra, K. F. Rabe, and P. J. Sterk Assessment of Microvascular Leakage via Sputum Induction: The Role of Substance P and Neurokinin A in Patients with Asthma Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1275 - 1279. [Abstract] [Full Text] [PDF]

				P. BRESSER, T. A. OUT, L. van ALPHEN, H. M. JANSEN, and R. LUTTER Airway Inflammation in Nonobstructive and Obstructive Chronic Bronchitis with Chronic Haemophilus influenzae Airway Infection . Comparison with Noninfected Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 947 - 952. [Abstract] [Full Text]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				R. E. T. NOCKER, F. R. WELLER, T. A. OUT, M. J. de RIEMER, H. M. JANSEN, and J. S. van der ZEE A Double-blind Study on the Effect of Inhaled Corticosteroids on Plasma Protein Exudation in Asthma Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1499 - 1505. [Abstract] [Full Text] [PDF]

				T. Kennedy, A. J. Ghio, W. Reed, J. Samet, J. Zagorski, J. Quay, J. Carter, L. Dailey, J. R. Hoidal, and R. B. Devlin Copper-dependent Inflammation and Nuclear Factor-kappa B Activation by Particulate Air Pollution Am. J. Respir. Cell Mol. Biol., September 1, 1998; 19(3): 366 - 378. [Abstract] [Full Text]